Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1988-02-12
1993-04-27
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Lymphokine
514 15, 530328, C07K 706
Patent
active
052060144
ABSTRACT:
The specification relates to a synthetic peptide converted into a salt comprising one or more amine groups and capable of potentiating in vivo the primary and secondary antibody response to thymo-dependent and thymo-independent antigens having low immunogenicity.
Injectable preparations comprising a solution of the peptide in a pharmacologically acceptable solvent are particularly useful as adjuvants in therapy.
REFERENCES:
patent: 4283328 (1981-08-01), Stammer
patent: 4774320 (1988-09-01), Tagliabue et al.
patent: 4845079 (1989-07-01), Luly et al.
March et al. Nature (1985) 315:641-647.
Auron et al. Proc. Nat. Acad. Sci. (1984) 81:7907-7911.
Bensi et al. Gene. (1987) 52:95-101.
Clark et al. Nucleic Acids Res. (1986) 14:7897-7914.
Antoni Guido
Boraschi Diana
Nencioni Luciano
Tagliabue Aldo
Lee Lester L.
Sclavo S.p.A.
LandOfFree
Synthetic nonapeptide for use as an adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic nonapeptide for use as an adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic nonapeptide for use as an adjuvant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2325446